NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Oppilotech

Oppilotech

Private
LondonHealthcare & Life Scienceshttps://oppilotech.com/

Last Round

Grant

Sep 1, 2023

Total Funding Raised

$1.95M

Company Overview

Oppilotech is a biotechnology company that utilizes systems biology and machine learning platforms to build predictive computational models of cells for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

computational biologydrug discoverysystems biologyantibiotic resistancein silico drug discoverybacterial modelinganti-infective therapydigital biologytarget identificationai drug discoverywhole-cell modelingbiotech platformdrug target discoverycomputational modelingpharma r&d

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oppilotech Comparables

Compare Oppilotech with similar companies based on industry and business-model similarity.

Oppilotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phare Bio
76%
Evariste
71%
Deep Origin
69%

Oppilotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2023
GrantMay 1, 2020
GrantApr 1, 2019
AcceleratorJul 11, 2018
GrantJan 1, 2018
Grant
Jul 1, 2017

Key People

Founding team and executive leadership

Ajay Mistry

Founder CEO

Founding Team

Oppilotech Investors

Notable investors and investment history

Oppilotech investors
InvestorRounds
CARB-XGrant
Innovate UKGrant
Accelerate@BabrahamAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2019

    $835K grant received from Innovate UK.

  • Apr 1, 2017

    $120K grant received from CARB-X

Oppilotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oppilotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oppilotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range10
Year Founded2014
Last FundingSep 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.